Oncolytics Biotech, Inc. Common Shares
Symbol: ONCY (NASDAQ)
1.29
▼ (-1.53%) -0.020
Company Description:
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
Key Stats
- Today's Open: $1.32
- Today's High: $1.345
- Today's Low: $1.285
- Today's Volume: 442.90K
- Yesterday Close: $1.31
- Yesterday High: $1.4
- Yesterday Low: $1.3
- Yesterday Volume: 1.73M
- Last Min Volume: 1.00K
- Last Min High: $1.29
- Last Min Low: $1.29
- Last Min VWAP: $1.29
Company Profile
- Name: Oncolytics Biotech, Inc. Common Shares
- Website: https://www.oncolyticsbiotech.com
- Listed Date: 2001-10-05
- Location: ,
- Market Status: Active
- CIK Number: 0001129928
- SIC Code:
- SIC description:
- Market Cap: $132.63M
- Round Lot: 100
- Outstanding Shares: 101.25M
- Asset Type: CS
RECENT FILINGS FOR ONCY
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | 6-K | View |
| 2025-09-02 | 6-K | View |
| 2025-08-29 | EFFECT | View |
| 2025-08-28 | 6-K | View |
| 2025-08-22 | F-3 | View |
| 2025-08-11 | 6-K | View |
| 2025-08-08 | 6-K | View |
| 2025-08-08 | 6-K | View |
| 2025-08-08 | 6-K | View |
| 2025-08-08 | 6-K | View |
| 2025-08-05 | 6-K | View |
| 2025-07-29 | 6-K | View |
| 2025-07-23 | 6-K | View |
| 2025-07-22 | 6-K | View |
| 2025-07-16 | 6-K | View |
| 2025-07-10 | 6-K | View |
| 2025-07-08 | 6-K | View |
| 2025-07-08 | 6-K | View |
| 2025-06-30 | 6-K | View |
| 2025-06-11 | 6-K | View |
Latest News on ONCY